 1.  Short title This Act may be cited as the  The Insulin Cost Reduction Act .
 2.  Prohibition of price concessions with respect to insulin drugs and exceptions under part D of Medicare  (a)  In general Section 1860D–2(d)(1) of the Social Security Act ( 42 U.S.C. 1395w–102(d)(1) ) is amended— (1) in subparagraph (A), by striking  Under  and inserting  Subject to subparagraph (D), under ; and (2)  by adding at the end the following new subparagraph:  (D)  Prohibition of price concessions with respect to insulin drugs and exceptions  For plan years beginning 180 days after the date of the enactment of this subparagraph, no price concessions negotiated between manufacturers and a prescription drug plan or MA–PD plan shall be permitted with respect to an insulin drug (as determined by the Secretary), unless—  (i)  such price concessions provided under such a plan shall be provided to enrollees of such a plan at pharmacies or by mail order service at the point-of-sale of such insulin drugs; or  (ii)  the cost-sharing required with respect to such insulin drugs shall be calculated in a manner that takes into account any amounts received pursuant to such price concessions.  . 
